Pelareorep Data Show HPV-Specific Immune Responses in Anal Cancer Patients

Translational data report more than doubled immune activation levels in nearly all patients after one treatment cycle, alongside increases in HPV-16-specific T cells and tumor-infiltrating lymphocytes.